Patrick Cox

Watching this administration pretend that refusing to raise the debt ceiling is the federal government’s real problem — rather than its spending — is simply surreal.

All the major players pushing for more debt, including the president, said exactly the opposite just a few years ago. Roughly, about the time The Daily Reckoning was filming and releasing I.O.U.S.A. Back then, the current powers-that-be were criticizing the prior administration, and rightly so, when the debt was $10 trillion.

Ha. Seems laughably trite, doesn’t it?

Now, when the debt is 60% higher, the same characters are feigning outrage that anybody would take their own prior position in support of a balanced budget.

There is upside to this behavior. Certainty.

We know certain big things will happen. Whenever you know that something big is going to happen, you can make money. And that’s, after all, why you read these pages… to learn how the government and economy actually work, then plan accordingly.

We can project what’s going to happen as a result of current and past fiscal foolishness. As Herbert Stein said, “what can’t go on, won’t.” Attempts to raise taxes further will lead to lower, not greater, revenues. The cost of borrowing will go up, curtailing debt growth and forcing spending cuts.

A primary justification used by this administration for increasing spending and debt has been the expansion of health care programs. The promise of lowering health care costs has already been exposed as a pipe dream, but it has done nothing to diminish the administration’s support of these programs.

In fact, health care costs are going to go up for several reasons, including the bureaucratic burden. Additionally, people are going to live longer while more and better therapies become available. Political pressures to reduce healthcare costs will be enormous.

We’re not speculating wildly, incidentally. Costs are already exploding in places where government established national health care systems earlier, including Canada and the U.K. Rationing, known in medical circles as triage, is reality.

Information is power. If you understand this trend, you can leverage that knowledge, reducing regulatory risk and maximizing ROI by investing in emerging biotechnologies that improve and lower the costs of current medical practices. If a biotechnology does something universally accepted as necessary but does it better and for less money, you have an almost certain blockbuster.

I’ve recommended one such technology to subscribers of my Breakthrough Technology Alert. The company behind this technology has improved continual glucose monitoring with an electronically controlled device that painlessly removes the top layer of dead skin cells, the stratum corneum.

Then, a needle-free sensor measures blood sugar levels in the capillary-rich epidermis and sends that information in real-time to whatever device you choose. Instead of paying nurses to repeatedly draw blood for testing, a constant flow of information is gathered, stored and electronically displayed, eliminating human error for any reading that for some reason is out of line with actual metabolic trends.

Several studies say that continual glucose monitoring can improve hospital outcomes, mortality and length of stay by a third. Cutting hospital stays by a third in a system that pays fixed fees for specific conditions yields huge financial benefits for hospitals. It also saves hours of nursing work every day for every patient having sugars monitored.

This looks to be a breakthrough year for this tiny company, with multiple trigger events coming up soon.

Regards,

Patrick Cox
for The Daily Reckoning

Patrick Cox

Patrick Cox has lived deep inside the world of transformative technologies for over 25 years. This expertise lead him to Mauldin Economics, where he now heads Transformational Technology Alert.

  • Robert (qslv)

    It’s a great technology, but goes completely against the agenda of the powerful pharmecutical lobby. People could stabilize their blood sugar in real time with diet and exercise, losing billions in sales for the big pharma. It would be crushed.

Recent Articles

Bill Bonner
An Easy Way to Avoid Pig-Headed Mistakes

Bill Bonner

Taken individually, most people perform relatively well in their daily lives. They get up, drive to work and interact with various other people, largely without incident. But when big groups of people get together, they can be incredibly pig-headed, demanding "action" when the best course of action would simply be inaction. And before you know it, chaos ensues. Bill Bonner explains...


Attack on America’s Most Important Pipeline

Byron King

America's most precious resource isn't oil, natural gas, gold or any other commodity. But it travels through an extensive pipeline that, if severed, could signal an unprecedented breach in U.S. security. What is this pipeline, and why is it so imperative that the U.S. take steps to protect it? Byron King explains...


3 Critical Correction Warnings

Greg Guenthner

The S&P 500 just clocked a new closing high last week, while the Dow and the Nasdaq both fell just short or their previous highs. But under the surface, you'll find a few bits of evidence pointing toward lower prices. And right now, there are seeing several warning signs that could point to market weakness. Greg Guenthner explains...


Extra!
Where You Can Make $56,000 a Year Delivering Pizzas

Jim Mosquera

US unemployment rates are some of the most dubious and debatable numbers in economics. And when you look at how the government fudges them it's easy to see why. Today Jim Mosquera attempts to make sense of them, and includes an insightful commentary on another controversial topic: minimum wage. Read on...


Addison Wiggin
The Quickest, Easiest Way to Store Your Wealth Overseas

Addison Wiggin

Over the years, the feds have made it increasingly difficult for you to maintain any semblance of financial freedom. So today, Addison Wiggin details one strategy that will go a long way to keeping them at bay, and allow you to keep more of your hard-earned money in the process. Read on...